Tuesday May 26, 2020

Cancer drug firm Carrick to begin ‘multi-portfolio’ clinical trials within year

Dublin-based firm aiming to fight aggressive forms of cancer has raised $95m from investors

Ian Guider

Markets Editor

@ianguider
9th October, 2016
Elaine Sullivan

Carrick Therapeutics, the Dublin-headquartered drug company launched last week, said it hopes to have its compounds for cancer treatments undergoing clinical trial in a year.

Co-founder Elaine Sullivan told The Sunday Business Post that the company was currently working with scientists on programmes to target three areas – using “molecular pathways” – to fight some of the most aggressive forms of cancer.

“We want to create a multi-portfolio [drug] company and we identified...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 3 weeks ago

What’s coming up today and what you might have missed

Hannah O’Brien | 5 months ago